Risk adjustment for medicare beneficiaries with Alzheimer's disease and related dementias

American Journal of Managed Care

Volumn 16, Issue 3, 2010, Pages 191-198

  Lin, Pei Jung ^a   Maciejewski, Matthew L ^b,c   Paul, John E ^d   Biddle, Andrea K ^d  

^a TUFTS MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; AGED; ALZHEIMER DISEASE; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; DEMENTIA; DEMOGRAPHY; DRUG COST; DRUG UTILIZATION; FEMALE; FUNCTIONAL STATUS; HEALTH CARE COST; HUMAN; MALE; MEDICAID; MEDICARE; MEDICATION THERAPY MANAGEMENT; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA; FEMALE; FORECASTING; HEALTH EXPENDITURES; HOSPITALS, VETERANS; HUMANS; INSURANCE CLAIM REVIEW; MALE; MEDICARE; RISK ADJUSTMENT; ROC CURVE; UNITED STATES;

EID: 77950817215     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Greenwald LM, Levy JM, Ingber MJ. Favorable selection in the Medicare+Choice program: new evidence. Health Care Financ Rev. 2000;21(3):127-134.
2. Pope GC, Kautter J, Ellis RP. et al. Risk adjustment of Medicare capitation payments using the CMS-HCC model. Health Care Financ Rev. 2004;25(4):119-141. (Pubitemid 39201560)
3. Kautter J, Pope GC. CMS frailty adjustment model. Health Care Financ Rev. 2004;26(2):1-19.
4. Riley GF. Risk adjustment for health plans disproportionately enrolling frail Medicare beneficiaries. Health Care Financ Rev. 2000;21(3):135-148.
5. Noyes K, Liu H, Temkin-Greener H. Medicare capitation model, functional status, and multiple comorbidities: model accuracy. Am J Manag Care. 2008;14(10):679-690.
6. Ayanian JZ. The elusive quest for quality and cost savings in the Medicare program. JAMA. 2009;301(6):668-670.
7. Reker DM, Rosen AK, Hoenig H, et al. The hazards of stroke case selection using administrative data. Med Care. 2002;40(2):96-104.
8. Baldwin LM, Klabunde CN, Green P. Barlow W, Wright G. In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care. 2006;44(8):745-753.
9. Maciejewski ML, Liu CF, Fihn SD. Performance of comorbidity, risk adjustment, and functional status measures in expenditure prediction for patients with diabetes. Diabetes Care. 2009;32(1):75-80.
10. Noyes K, Liu H, Temkin-Greener H. Cost of caring for Medicare beneficiaries with Parkinson's disease: impact of the CMS-HCC risk-adjustment model. Dis Manag. 2006;9(6):339-348.
11. Meenan RT, Goodman MJ, Fishman PA, Hombrook MC, O'Keeffe-Rosetti MC, Bachman DJ. Using risk-adjustment models to identify high-cost risks. Med Care. 2003;41(11):1301-1312.
12. Forrest CB, Lemke KW, Bodycombe DP. Weiner JR. Medication, diagnostic, and cost information as predictors of high-risk patients in need of care management. Am J Manag Care. 2009;15(1):41-48.
13. Centers for Medicare & Medicaid Services. Overview. Medicare Current Beneficiary Survey (MCBS). Page last modified on December 14. 2005. http://www.cms.hhs.gov/MCBS/. Accessed November 1, 2006.
14. Newcomer R, Clay T, Luxenberg JS, Miller RH. Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records. J Am Geriatr Soc. 1999;47(2):215-219. (Pubitemid 29082722)
15. Lin PJ, Kaufer DI, Maciejewski ML, Ganguly R, Paul JE, Biddle AK. An examination of Alzheimer's case definitions using Medicare claims and survey data. Alzheimers Dement. In press.
16. Hill JW, Futterman R, Duttagupta S, Mastey V, Lloyd JR, Fillit H. Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare. Neurology. 2002;58(1):62-70. (Pubitemid 34041939)
17. Gutterman EM, Markowitz JS, Lewis B, Fillit H. Cost of Alzheimer's disease and related dementia in managed-medicare. J Am Geriatr Soc. 1999;47(9):1065-1071. (Pubitemid 29420611)
18. Hill J, Fillit H, Thomas SK, Chang S. Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer's disease and other dementias. Pharmacoeconomics. 2006;24(3):265-280. (Pubitemid 43374378)
19. Robst J, Levy JM, lngber MJ. Diagnosis-based risk adjustment for medicare prescription drug plan payments. Health Care Financ Rev. 2007;28(4):15-30. (Pubitemid 47173624)
20. Ellis RP, Pope GC, Iezzoni L, et al. Diagnosis-based risk adjustment for Medicare capitation payments. Health Care Financ Rev. 1996;17(3):101-128. (Pubitemid 26178934)
21. Alzheimer's Association. 2009 Alzheimer's Disease Facts and Figures. http://www.alz.org/alzheimers-disease--facts-figures.asp. Accessed February 15, 2010.
22. Centers for Medicare & Medicaid Services. Appendix A: Technical Documentation for the Medicare Current Beneficiary Survey. 2003. http://www.cms.hhs.gov/mcbs/downloads/HHC2003appendixA.pdf. Accessed October 10, 2007.
23. Centers for Medicare & Medicaid Services. Risk adjustment model software. 2007. http://www.cms.hhs.gov/MedicareAdvtgSpecRateStats/06-Risk- adjustment.asp#TopOfPageCMS. Accessed December 15,2007.
24. Winkelman R, Mehmud S. A Comparative Analysis of Claims-Based Tools for Health Risk Assessment. Society of Actuaries. April 20, 2007. http://www.soa.org/files/pdf/risk-assessmentc.pdf. Accessed February 15, 2010.
25. Kronick R, Dreyfus T, Lee L, Zhou Z. Diagnostic risk adjustment for Medicaid: the disability payment system. Health Care Financ Rev. 1996;17(3):7-33. (Pubitemid 26178930)
26. Kronick R, Gilmer T, Dreyfus T, Ganiats TG. CDPS-Medicare:The Chronic Illness and Disability Payment System modified to predict expenditures for Medicare beneficiaries. Final report to CMS. June 24, 2002. http://cdps.ucsd. edu/CDPS-Medicare.pdf. Accessed January 25, 2008.
27. Charlson ME, Pompei P. Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
28. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity in- dex for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
29. Kuo TC, Zhao Y, Weir S, Kramer MS, Ash AS. Implications of comorbidity on costs for patients with Alzheimer disease. Med Care. 2008;46(8):839-846.
30. Lin PJ, Biddle AK, Ganguly R, Kaufer DI, Maciejewski ML. The concentration and persistence of health care expenditures and prescription drug expenditures in Medicare beneficiaries with Alzheimer's disease and related dementias. Med Care. 2009;47(11):1174-1179.
31. Maciejewski ML, Liu CF, Derleth A, McDonell M.Anderson S, Fihn SD.The performance of administrative and self-reported measures for risk adjustment of Veterans Affairs expenditures. Health Serv Res. 2005;40(3):887-904. (Pubitemid 40791621)
32. Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ. 2005;24(3):465-488. (Pubitemid 40461909)
33. Ash AS, Ellis RP. Pope GC, et al. Using diagnoses to describe populations and predict costs. Health Care Financ Rev. 2000;21(3):7-28.
34. Newhouse JP, Manning WG, Keeler EB, Sloss EM. Adjusting capitation rates using objective health measures and prior utilization. Health Care Financ Rev. 1989;10(3):41-54.
35. Zhao Y, Ash AS, Ellis RP. et al. Predicting pharmacy costs and other medical costs using diagnoses and drug claims. Med Care. 2005;43(1):34-43. (Pubitemid 40137612)
36. Wrobel MV, Doshi J, Stuart BC, Briesacher B. Predictability of prescription drug expenditures for Medicare beneficiaries. Health Care Financ Rev. 2003;25(2):37-46. (Pubitemid 38500730)
37. Ash AS, Zhao Y, Ellis RP. Schlein Kramer M. Finding future high-cost cases: comparing prior cost versus diagnosis-based methods. Health Serv Res. 2001;36(6 pt 2):194-206.
38. Taylor DH Jr, Schenkman M, Zhou J, Sloan FA. The relative effect of Alzheimer's disease and related dementias, disability, and comorbidities on cost of care for elderly persons [published correction appears in J Gerontol B Psychol Sci Soc Sci. 2003;58(3):S198]. J Gerontol B Psychol Sci Soc Sci. 2001;56(5):S285-S293.
39. Fishman PA, Goodman MJ, Hombrook MC, Meenan RT, Bachman DJ, O'Keeffe Rosetti MC. Risk adjustment using automated ambulatory pharmacy data: the RxRisk model. Med Care. 2003;41(1):84-99. ■